Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6–9 years excess risk in individuals with familial hypercholesterolemia

被引：0
|
作者：
Anneke Kramer
Angelique CM Jansen
Emily S van Aalst-Cohen
Michael WT Tanck
John JP Kastelein
Aeilko H Zwinderman
机构：
[1] University of Amsterdam,Department of Medical Informatics, Academic Medical Center
[2] University of Amsterdam,Department of Vascular Medicine, Academic Medical Center
[3] University of Amsterdam,Department of Clinical Epidemiology and Biostatistics, Academic Medical Center
来源：
BMC Public Health | / 6卷
关键词：
Smoking Cessation; Acute Myocardial Infarction; Smoking History; Excess Risk; Familial Hypercholesterolemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry
    Perez de Isla, Leopoldo
    Arroyo-Olivares, Raquel
    Alonso, Rodrigo
    Muniz-Grijalvo, Ovidio
    Luis Diaz-Diaz, Jose
    Zambon, Daniel
    Fuentes, Francisco
    Mata, Nelva
    Piedecausa, Mar
    Dolores Manas, M.
    Sanchez Munoz-Torrero, Juan F.
    Pablo Miramontes-Gonzalez, Jose
    de Andres, Raimundo
    Mauri, Marta
    Aguado, Rocio
    Brea, Angel
    Cepeda, Jose M.
    Vidal-Pardo, Jose, I
    Martinez-Faedo, Ceferino
    Angel Barba, Miguel
    Argueso, Rosa
    Ruiz-Perez, Enrique
    Michan, Alfredo
    Arrieta, Francisco
    Riestra Fernandez, Maria
    Perez, Leire
    Pinilla, Jose M.
    Diaz-Soto, Gonzalo
    Pinto, Xavier
    Padro, Teresa
    Badimon, Lina
    Mata, Pedro
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (10): : 828 - 834
  • [22] Choice of initial treatment with cholesterol lowering drugs in patients with familial hypercholesterolemia, atherosclerotic cardiovascular disease, or increased risk of atherosclerotic cardiovascular disease
    Hoe, Jakob Kronkvist
    Jensen, Camilla B.
    Hansen, Susanne
    Olsen, Rasmus Huan
    Johansen, Tina
    Jimenez-Solem, Espen
    Petersen, Janne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 178 - 179
  • [23] Risk of metabolic syndrome persists twenty years after the cessation of smoking
    Wada, Takashi
    Urashima, Mitsuyoshi
    Fukumoto, Tsutomu
    INTERNAL MEDICINE, 2007, 46 (14) : 1079 - 1082
  • [24] Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study
    Svanstrom, Henrik
    Pasternak, Bjorn
    Hviid, Anders
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [25] Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm
    Alothman, Latifah
    Zawadka, Magdaline
    Aljenedil, Sumayah
    Kajil, Mahesh
    Bewick, David
    Gaudet, Daniel
    Hegele, Robert A.
    Lonn, Eva
    Ngui, Daniel
    Ruel, Isabelle
    Tsigoulis, Michelle
    Singh, Narendra
    Genest, Jacques
    Gupta, Milan
    CJC OPEN, 2019, 1 (04) : 190 - 197
  • [26] UNDERDIAGNOSIS, UNDERTREATMENT AND CARDIOVASCULAR RISK MISPERCEPTION AMONG INDIVIDUALS WITH SUSPECTED FAMILIAL HYPERCHOLESTEROLEMIA: A BRAZILIAN SURVEY
    Bittencourt, Marcio
    Laurinavicius, Antonio
    Pereira, Carolina
    Cesena, Fernando
    Conceicao, Raquel
    Santos, Raul D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 48 - 48
  • [27] Lipoprotein (a), an additional risk factor for the occurrence of cardiovascular events in high-risk patient groups with monogenic familial hypercholesterolemia, polygenic familial hypercholesterolemia or type 2 diabetes
    del Marmol, Gregoire
    Aksel, Ysar
    Descamps, Olivier
    ACTA CARDIOLOGICA, 2020, 75 : 49 - 50
  • [28] Prognostic risk factors for cardiovascular events, in subjects with familial hypercholesterolemia: 15 years follow-up (1987-2002)
    Skoumas, J
    Pitsavos, C
    Panagiotakos, DB
    Papaioannou, N
    Skoumbourdis, J
    Toutouza, M
    Stefanadis, C
    Toutouzas, PK
    EUROPEAN HEART JOURNAL, 2002, 23 : 629 - 629
  • [29] Prevalence and Risk Factors for Atherosclerotic Cardiovascular Disease in 7704 Individuals: An Analysis from the Greek Registry for the Prevalence of Familial Hypercholesterolemia (GRegistry-FH)
    Kolovou, Genovefa
    Makrygiannis, Stamatis
    Marvaki, Christina
    Pavlatou, Niki
    Anagnostopoulou, Katerina
    Giannakopoulou, Vasiliki
    Goumas, Georgios
    Kalogeropoulos, Petros
    Kolovou, Vana
    Limberi, Sotiria
    Perrea, Despina
    Tzenalis, Anastasios
    Emre, Zeimpek
    Jahaj, Edison
    Kasiara, Zoi
    Giannakoulis, Ilias
    Tsolakoglou, Ioannis
    Kadda, Olga
    Tsaloukidis, Nikolaos
    Koulaxidou, Rafailia
    Marvaki, Aikaterini
    Foussas, Stefanos
    Melidonis, Andreas
    Hoursalas, Giannis
    Vlachopoulos, Charalambos
    Katsiki, Niki
    Milionis, Haralampos
    Liberopoulos, Evaggelos
    Bilianou, Helen
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (12)
  • [30] Response by Paquette and Baass to Letter Regarding Article, "Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia"
    Paquette, Martine
    Baass, Alexis
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (12) : E526 - E527
12345